All Regulation articles
View all stories with this category.
-
BusinessNitrosamine contamination withdrawals spread to new drugs
After ranitidine recalls, EU regulators instruct companies to review all their products for potential impurities
-
Opinion
Is bankruptcy best for Purdue?
Many would prefer to see the Sackler family held personally liable, and the company wound down
-
Business
Chemical firms urged to plan for no-deal Brexit
European Chemicals Agency highlights hundreds of chemicals whose Reach registrations would be voided
-
Opinion
Will Novartis's data manipulation damage relations with regulators?
Trust between the two has been compromised
-
News
Concerns raised over ‘regrettable’ BPA substitutions
Research indicates chemicals used as alternatives to bisphenol A in polycarbonate plastics and epoxy resins aren’t always safer
-
News
Data manipulation casts shadows on Novartis gene therapy
Manufacturing problems with other new medicines highlight difficulty of developing advanced treatments
-
Opinion
Are new drugs better than existing ones?
Should companies be made to change the way they run clinical trials?
-
Business
US ditches chlorpyrifos ban for food crops
Environmental Protection Agency says evidence of harm from food residues is insufficient
-
Business
US judges slash damages in glyphosate cancer lawsuits
While upholding rulings linking the herbicide to cancer, judges have cut Bayer-Monsanto’s fines from billions to tens of millions of dollars
-
News
UK MPs criticise government inaction on harmful chemicals
A report calls for urgent changes to the way flame retardants and packaging additives are regulated
-
Business
China makes slow progress on safety
Government policy drive continues, as self-regulation also grows
-
Business
US finalises guidance on biosimilars
Regulator clarifies requirements for allowing substitution between products
-
Business
Industry criticises proposed US asbestos ban
Outright ban would compromise chlorine supply and public health, claims trade body
-
News
International commission launched to tackle tough questions around gene-editing
US and UK scientific academies have convened a new body charged with developing a global framework for heritable human genome editing
-
Business
Emerging from the US opioid crisis
With litigation against suppliers in full swing, how does the US counter its addiction to powerful painkillers?
-
News
Forensic science failures putting justice at risk in England and Wales
Damning House of Lords report says cuts and bureaucracy may result in the market for forensics becoming dysfunctional
-
News
Anhydrous ammonia leak in the US hospitalises 38
Two people remain in hospital in a serious condition after the material leaked from an agricultural transport outside of Chicago
-
Opinion
Show me the data
Making industrial safety research more transparent benefits both companies and consumers
-
News
New US asbestos rule criticised as outright ban on the carcinogen ditched
Environment agency issues policy that requires companies to seek approval for discontinued uses of the material
-
News
Predatory publisher OMICS fined $50 million by US court for defrauding scientists
Underhand tactics of predatory open access firm revealed in case brought by the Federal Trade Commission
